4D Molecular Therapeutics

Provide strategic and operational leadership for global clinical trial execution across the lung portfolio, ensuring programs align with corporate timelines and budgets. Lead internal teams and external CROs to deliver high-quality, inspection-ready Phase 1-3 clinical studies.

The Executive Director will lead a team of translational scientists to advance innovative gene therapies from concept through Phase 1-2 clinical testing. They are responsible for setting scientific strategy, managing preclinical pharmacology and toxicology programs, and overseeing collaborations with external CROs and internal stakeholders.